Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
about
Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomasHematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsThe ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implicationsPurging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy.Flanking-sequence exponential anchored-polymerase chain reaction amplification: a sensitive and highly specific method for detecting retroviral integrant-host-junction sequences.Autologous blood stem cell transplantation in hematological malignancies.The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission.Gene therapy for diseases of the nervous system.Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.The potential for monocyte-mediated immunotherapy during infection and malignancy--Part II: in vivo activation by exogenous cytokines and clinical applications.Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance.A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells.Update on gene therapy for immunodeficiencies.Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes.Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cellsGene therapy in human cancer: report of human clinical trials.Using peripheral blood progenitor cells (PBPC) for transplantation in pediatric patients: a state-of-the-art review.Gene transfer and the treatment of haematological malignancy.Current status of retroviral vector mediated gene transfer into human hematopoietic stem cells.Gene therapy: here to stay.Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates after CD34+ hematopoietic cell transduction with cell-free retroviral vector preparations.Back to the future! The evolving role of maintenance therapy after hematopoietic stem cell transplantation.Detection of occult tumour cells in bone marrow and blood in breast cancer patients--methods and clinical significance.Gene therapy for paediatric leukaemia.Adenovirus infection of primary malignant lymphoid cells.Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma?Contributions of gene marking to cell and gene therapies.Bone marrow transplant in Ph+ ALL patients.Harvesting, processing and inventory management of peripheral blood stem cellsNovel viral vector systems for gene therapy.Oncolytic virotherapy for hematological malignancies.Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors.Stem cell transplantation in follicular lymphoma: progress at last?Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells.A concise peer into the background, initial thoughts and practices of human gene therapy.High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia.Genetic engineering: moral aspects and control of practiceCAR-T Cell Therapy for Lymphoma.In vitro culture during retroviral transduction improves thymic repopulation and output after total body irradiation and autologous peripheral blood progenitor cell transplantation in rhesus macaques
P2860
Q24657196-C6195A71-3C5E-40F0-BC16-8C11EE4347A8Q26859147-39A5F2B0-3697-493D-AC5B-E7980D1F1280Q27002660-2BBCA77D-636F-4385-B313-6CAC2E0F0A5DQ33227071-D1904198-B062-481D-A8B3-4D4A8ADEFBBEQ33372388-2E998784-263F-469E-A916-A3562C59A04BQ33491628-0D13EF72-971F-48C1-95A4-55D762B544AAQ33499949-027F85BE-4F61-48B3-A767-6D7A62BF9435Q33582065-B5A17C6D-EFEA-44FA-ABD5-E1D4A2C56A3DQ33656184-B4AA354D-1FA8-4BB6-AE53-269C39F256ABQ33706507-8A789609-2BF9-4919-B165-2114D978DD66Q33723603-3593D4E3-DBEF-4829-BE19-89DCF17C985EQ33750950-AD7616DD-7FFB-42C5-8BE8-2EF5AFCB1389Q33798427-FA4BB60B-9F5C-4AD8-AA37-1A0AA77F94DAQ33804205-AAA68CB3-5CDA-46D7-B007-3B4F2D90D068Q33959862-F16E7E96-F42C-4918-B61B-F76A0BEB754CQ34099395-54EE5F55-6E98-424A-A17C-B6A5EE916C3DQ34165168-5B994C4D-F456-496E-BC7F-1022772EF0A4Q34216677-B4249D4F-54B3-48B6-B5BB-3EEAC4734918Q34244510-A102EDB6-7B8E-43FA-B648-AD0087405383Q34279082-7BC0F080-0893-4133-BBD2-5A3CC0C5B834Q34326769-685FB1C8-5050-4520-A686-FB782580A083Q34380489-9C9576C5-D642-4FCC-AB8A-36449985C44BQ34419772-D7883FF3-5CD3-45E8-BE3A-D870C67457D8Q34451905-CC39D94B-F37F-4C8C-BC91-C243936D0987Q34573981-3740D2FE-5B7D-471A-BCFD-720B7001E354Q35022123-2261352A-D1FC-4C15-B911-C2C4CF27D766Q35059829-C07C9468-C874-4E3C-84E6-0268B2F72D08Q35106125-9D81DE86-9F54-4294-985D-FBA4254397B9Q35199782-A8BA96D4-D318-4AA9-ACFC-71207FF82E08Q35260938-7FABD53E-3AE3-46D5-B09E-FF4F29FE602DQ35692095-215C1EDA-AD75-4AC6-8735-D6538E00374BQ35869915-E468C5A8-5633-4BA0-8BC7-F8DF3445ED1CQ35920882-DF793300-85AB-4F75-B233-26E2CB240555Q35941149-294A1EAB-9170-4DB3-81DA-0677EFE84EDAQ36098953-72BF2824-1F96-42E8-8972-14FE48525556Q36115468-9046D011-C7F0-4A35-9122-C47814A84EC4Q36255287-D3364F64-D7D3-42B4-AF25-30CC7CD32F34Q36267781-16EF2544-9C06-4EBF-9446-38A3A276A851Q36519358-6281DB2B-0E63-4E7F-A1A4-F026892C452FQ36618076-B5ED9842-11DD-4167-B54D-140CA32C56E8
P2860
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
@en
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
@nl
type
label
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
@en
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
@nl
prefLabel
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
@en
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
@nl
P2093
P1433
P1476
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
@en
P2093
M K Brenner
R A Krance
W F Anderson
P356
10.1016/0140-6736(93)92560-G
P407
P577
1993-01-01T00:00:00Z